The Animal Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Animal Stem Cell Therapy market size is estimated to be worth US$ 63 million in 2021 and is forecast to a readjusted size of USD 80 million by 2028 with a CAGR of 3.5% during review period. Veterinary Hospitals accounting for % of the Animal Stem Cell Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dogs Stem Cell Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Animal Stem Cell Therapy include Medivet Biologics LLC, VETSTEM BIOPHARMA, J-ARM, U.S. Stem Cell, Inc, and VetCell Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Animal Stem Cell Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others Animals
Market segment by Application, can be divided into
Veterinary Hospitals
Research Organizations
Market segment by players, this report covers
Medivet Biologics LLC
VETSTEM BIOPHARMA
J-ARM
U.S. Stem Cell, Inc
VetCell Therapeutics
Celavet Inc.
Magellan Stem Cells
Kintaro Cells Power
Animal Stem Care
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Animal Stem Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Animal Stem Cell Therapy, with revenue, gross margin and global market share of Animal Stem Cell Therapy from 2019 to 2022.
Chapter 3, the Animal Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Animal Stem Cell Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Animal Stem Cell Therapy research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Animal Stem Cell Therapy
1.2 Classification of Animal Stem Cell Therapy by Type
1.2.1 Overview: Global Animal Stem Cell Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Animal Stem Cell Therapy Revenue Market Share by Type in 2021
1.2.3 Dogs Stem Cell Therapy
1.2.4 Horses Stem Cell Therapy
1.2.5 Others Animals
1.3 Global Animal Stem Cell Therapy Market by Application
1.3.1 Overview: Global Animal Stem Cell Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Veterinary Hospitals
1.3.3 Research Organizations
1.4 Global Animal Stem Cell Therapy Market Size & Forecast
1.5 Global Animal Stem Cell Therapy Market Size and Forecast by Region
1.5.1 Global Animal Stem Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Animal Stem Cell Therapy Market Size by Region, (2017-2022)
1.5.3 North America Animal Stem Cell Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Animal Stem Cell Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Animal Stem Cell Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Animal Stem Cell Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Animal Stem Cell Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal Stem Cell Therapy Market Drivers
1.6.2 Animal Stem Cell Therapy Market Restraints
1.6.3 Animal Stem Cell Therapy Trends Analysis
2 Company Profiles
2.1 Medivet Biologics LLC
2.1.1 Medivet Biologics LLC Details
2.1.2 Medivet Biologics LLC Major Business
2.1.3 Medivet Biologics LLC Animal Stem Cell Therapy Product and Solutions
2.1.4 Medivet Biologics LLC Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Medivet Biologics LLC Recent Developments and Future Plans
2.2 VETSTEM BIOPHARMA
2.2.1 VETSTEM BIOPHARMA Details
2.2.2 VETSTEM BIOPHARMA Major Business
2.2.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Product and Solutions
2.2.4 VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 VETSTEM BIOPHARMA Recent Developments and Future Plans
2.3 J-ARM
2.3.1 J-ARM Details
2.3.2 J-ARM Major Business
2.3.3 J-ARM Animal Stem Cell Therapy Product and Solutions
2.3.4 J-ARM Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 J-ARM Recent Developments and Future Plans
2.4 U.S. Stem Cell, Inc
2.4.1 U.S. Stem Cell, Inc Details
2.4.2 U.S. Stem Cell, Inc Major Business
2.4.3 U.S. Stem Cell, Inc Animal Stem Cell Therapy Product and Solutions
2.4.4 U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 U.S. Stem Cell, Inc Recent Developments and Future Plans
2.5 VetCell Therapeutics
2.5.1 VetCell Therapeutics Details
2.5.2 VetCell Therapeutics Major Business
2.5.3 VetCell Therapeutics Animal Stem Cell Therapy Product and Solutions
2.5.4 VetCell Therapeutics Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 VetCell Therapeutics Recent Developments and Future Plans
2.6 Celavet Inc.
2.6.1 Celavet Inc. Details
2.6.2 Celavet Inc. Major Business
2.6.3 Celavet Inc. Animal Stem Cell Therapy Product and Solutions
2.6.4 Celavet Inc. Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Celavet Inc. Recent Developments and Future Plans
2.7 Magellan Stem Cells
2.7.1 Magellan Stem Cells Details
2.7.2 Magellan Stem Cells Major Business
2.7.3 Magellan Stem Cells Animal Stem Cell Therapy Product and Solutions
2.7.4 Magellan Stem Cells Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Magellan Stem Cells Recent Developments and Future Plans
2.8 Kintaro Cells Power
2.8.1 Kintaro Cells Power Details
2.8.2 Kintaro Cells Power Major Business
2.8.3 Kintaro Cells Power Animal Stem Cell Therapy Product and Solutions
2.8.4 Kintaro Cells Power Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Kintaro Cells Power Recent Developments and Future Plans
2.9 Animal Stem Care
2.9.1 Animal Stem Care Details
2.9.2 Animal Stem Care Major Business
2.9.3 Animal Stem Care Animal Stem Cell Therapy Product and Solutions
2.9.4 Animal Stem Care Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Animal Stem Care Recent Developments and Future Plans
2.10 Animal Cell Therapies
2.10.1 Animal Cell Therapies Details
2.10.2 Animal Cell Therapies Major Business
2.10.3 Animal Cell Therapies Animal Stem Cell Therapy Product and Solutions
2.10.4 Animal Cell Therapies Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Animal Cell Therapies Recent Developments and Future Plans
2.11 Cell Therapy Sciences
2.11.1 Cell Therapy Sciences Details
2.11.2 Cell Therapy Sciences Major Business
2.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Product and Solutions
2.11.4 Cell Therapy Sciences Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Cell Therapy Sciences Recent Developments and Future Plans
2.12 Animacel
2.12.1 Animacel Details
2.12.2 Animacel Major Business
2.12.3 Animacel Animal Stem Cell Therapy Product and Solutions
2.12.4 Animacel Animal Stem Cell Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Animacel Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Animal Stem Cell Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Animal Stem Cell Therapy Players Market Share in 2021
3.2.2 Top 10 Animal Stem Cell Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Animal Stem Cell Therapy Players Head Office, Products and Services Provided
3.4 Animal Stem Cell Therapy Mergers & Acquisitions
3.5 Animal Stem Cell Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Animal Stem Cell Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Animal Stem Cell Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Animal Stem Cell Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Animal Stem Cell Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Animal Stem Cell Therapy Revenue by Type (2017-2028)
6.2 North America Animal Stem Cell Therapy Revenue by Application (2017-2028)
6.3 North America Animal Stem Cell Therapy Market Size by Country
6.3.1 North America Animal Stem Cell Therapy Revenue by Country (2017-2028)
6.3.2 United States Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Animal Stem Cell Therapy Revenue by Type (2017-2028)
7.2 Europe Animal Stem Cell Therapy Revenue by Application (2017-2028)
7.3 Europe Animal Stem Cell Therapy Market Size by Country
7.3.1 Europe Animal Stem Cell Therapy Revenue by Country (2017-2028)
7.3.2 Germany Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
7.3.3 France Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Animal Stem Cell Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Animal Stem Cell Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Animal Stem Cell Therapy Market Size by Region
8.3.1 Asia-Pacific Animal Stem Cell Therapy Revenue by Region (2017-2028)
8.3.2 China Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
8.3.5 India Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Animal Stem Cell Therapy Revenue by Type (2017-2028)
9.2 South America Animal Stem Cell Therapy Revenue by Application (2017-2028)
9.3 South America Animal Stem Cell Therapy Market Size by Country
9.3.1 South America Animal Stem Cell Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Animal Stem Cell Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Animal Stem Cell Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Animal Stem Cell Therapy Market Size by Country
10.3.1 Middle East & Africa Animal Stem Cell Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Animal Stem Cell Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Animal Stem Cell Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Animal Stem Cell Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Animal Stem Cell Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Animal Stem Cell Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Animal Stem Cell Therapy Revenue Market Share by Region (2023-2028)
Table 6. Medivet Biologics LLC Corporate Information, Head Office, and Major Competitors
Table 7. Medivet Biologics LLC Major Business
Table 8. Medivet Biologics LLC Animal Stem Cell Therapy Product and Solutions
Table 9. Medivet Biologics LLC Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. VETSTEM BIOPHARMA Corporate Information, Head Office, and Major Competitors
Table 11. VETSTEM BIOPHARMA Major Business
Table 12. VETSTEM BIOPHARMA Animal Stem Cell Therapy Product and Solutions
Table 13. VETSTEM BIOPHARMA Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. J-ARM Corporate Information, Head Office, and Major Competitors
Table 15. J-ARM Major Business
Table 16. J-ARM Animal Stem Cell Therapy Product and Solutions
Table 17. J-ARM Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. U.S. Stem Cell, Inc Corporate Information, Head Office, and Major Competitors
Table 19. U.S. Stem Cell, Inc Major Business
Table 20. U.S. Stem Cell, Inc Animal Stem Cell Therapy Product and Solutions
Table 21. U.S. Stem Cell, Inc Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. VetCell Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. VetCell Therapeutics Major Business
Table 24. VetCell Therapeutics Animal Stem Cell Therapy Product and Solutions
Table 25. VetCell Therapeutics Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Celavet Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Celavet Inc. Major Business
Table 28. Celavet Inc. Animal Stem Cell Therapy Product and Solutions
Table 29. Celavet Inc. Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Magellan Stem Cells Corporate Information, Head Office, and Major Competitors
Table 31. Magellan Stem Cells Major Business
Table 32. Magellan Stem Cells Animal Stem Cell Therapy Product and Solutions
Table 33. Magellan Stem Cells Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Kintaro Cells Power Corporate Information, Head Office, and Major Competitors
Table 35. Kintaro Cells Power Major Business
Table 36. Kintaro Cells Power Animal Stem Cell Therapy Product and Solutions
Table 37. Kintaro Cells Power Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Animal Stem Care Corporate Information, Head Office, and Major Competitors
Table 39. Animal Stem Care Major Business
Table 40. Animal Stem Care Animal Stem Cell Therapy Product and Solutions
Table 41. Animal Stem Care Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Animal Cell Therapies Corporate Information, Head Office, and Major Competitors
Table 43. Animal Cell Therapies Major Business
Table 44. Animal Cell Therapies Animal Stem Cell Therapy Product and Solutions
Table 45. Animal Cell Therapies Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Cell Therapy Sciences Corporate Information, Head Office, and Major Competitors
Table 47. Cell Therapy Sciences Major Business
Table 48. Cell Therapy Sciences Animal Stem Cell Therapy Product and Solutions
Table 49. Cell Therapy Sciences Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Animacel Corporate Information, Head Office, and Major Competitors
Table 51. Animacel Major Business
Table 52. Animacel Animal Stem Cell Therapy Product and Solutions
Table 53. Animacel Animal Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Animal Stem Cell Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Animal Stem Cell Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Animal Stem Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Animal Stem Cell Therapy Players Head Office, Products and Services Provided
Table 58. Animal Stem Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 59. Animal Stem Cell Therapy New Entrants and Expansion Plans
Table 60. Global Animal Stem Cell Therapy Revenue (USD Million) by Type (2017-2022)
Table 61. Global Animal Stem Cell Therapy Revenue Share by Type (2017-2022)
Table 62. Global Animal Stem Cell Therapy Revenue Forecast by Type (2023-2028)
Table 63. Global Animal Stem Cell Therapy Revenue by Application (2017-2022)
Table 64. Global Animal Stem Cell Therapy Revenue Forecast by Application (2023-2028)
Table 65. North America Animal Stem Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Animal Stem Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Animal Stem Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Animal Stem Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Animal Stem Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Animal Stem Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Animal Stem Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Animal Stem Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Animal Stem Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Animal Stem Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Animal Stem Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Animal Stem Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Animal Stem Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Animal Stem Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Animal Stem Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Animal Stem Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Animal Stem Cell Therapy Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Animal Stem Cell Therapy Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Animal Stem Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Animal Stem Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Animal Stem Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Animal Stem Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Animal Stem Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Animal Stem Cell Therapy Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Animal Stem Cell Therapy Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Animal Stem Cell Therapy Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Animal Stem Cell Therapy Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Animal Stem Cell Therapy Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Animal Stem Cell Therapy Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Animal Stem Cell Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Animal Stem Cell Therapy Picture
Figure 2. Global Animal Stem Cell Therapy Revenue Market Share by Type in 2021
Figure 3. Dogs Stem Cell Therapy
Figure 4. Horses Stem Cell Therapy
Figure 5. Others Animals
Figure 6. Animal Stem Cell Therapy Revenue Market Share by Application in 2021
Figure 7. Veterinary Hospitals Picture
Figure 8. Research Organizations Picture
Figure 9. Global Animal Stem Cell Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Animal Stem Cell Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Animal Stem Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 12. Global Animal Stem Cell Therapy Revenue Market Share by Region in 2021
Figure 13. North America Animal Stem Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Animal Stem Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Animal Stem Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Animal Stem Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Animal Stem Cell Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Animal Stem Cell Therapy Market Drivers
Figure 19. Animal Stem Cell Therapy Market Restraints
Figure 20. Animal Stem Cell Therapy Market Trends
Figure 21. Medivet Biologics LLC Recent Developments and Future Plans
Figure 22. VETSTEM BIOPHARMA Recent Developments and Future Plans
Figure 23. J-ARM Recent Developments and Future Plans
Figure 24. U.S. Stem Cell, Inc Recent Developments and Future Plans
Figure 25. VetCell Therapeutics Recent Developments and Future Plans
Figure 26. Celavet Inc. Recent Developments and Future Plans
Figure 27. Magellan Stem Cells Recent Developments and Future Plans
Figure 28. Kintaro Cells Power Recent Developments and Future Plans
Figure 29. Animal Stem Care Recent Developments and Future Plans
Figure 30. Animal Cell Therapies Recent Developments and Future Plans
Figure 31. Cell Therapy Sciences Recent Developments and Future Plans
Figure 32. Animacel Recent Developments and Future Plans
Figure 33. Global Animal Stem Cell Therapy Revenue Share by Players in 2021
Figure 34. Animal Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Animal Stem Cell Therapy Revenue Market Share in 2021
Figure 36. Global Top 10 Players Animal Stem Cell Therapy Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Animal Stem Cell Therapy Revenue Share by Type in 2021
Figure 39. Global Animal Stem Cell Therapy Market Share Forecast by Type (2023-2028)
Figure 40. Global Animal Stem Cell Therapy Revenue Share by Application in 2021
Figure 41. Global Animal Stem Cell Therapy Market Share Forecast by Application (2023-2028)
Figure 42. North America Animal Stem Cell Therapy Sales Market Share by Type (2017-2028)
Figure 43. North America Animal Stem Cell Therapy Sales Market Share by Application (2017-2028)
Figure 44. North America Animal Stem Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 45. United States Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Animal Stem Cell Therapy Sales Market Share by Type (2017-2028)
Figure 49. Europe Animal Stem Cell Therapy Sales Market Share by Application (2017-2028)
Figure 50. Europe Animal Stem Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 51. Germany Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Animal Stem Cell Therapy Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Animal Stem Cell Therapy Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Animal Stem Cell Therapy Revenue Market Share by Region (2017-2028)
Figure 59. China Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Animal Stem Cell Therapy Sales Market Share by Type (2017-2028)
Figure 66. South America Animal Stem Cell Therapy Sales Market Share by Application (2017-2028)
Figure 67. South America Animal Stem Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Animal Stem Cell Therapy Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Animal Stem Cell Therapy Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Animal Stem Cell Therapy Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Animal Stem Cell Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source